GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Ortho Clinical Diagnostics Holdings PLC (NAS:OCDX) » Definitions » ROIC %

Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) ROIC % : 5.64% (As of Mar. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Ortho Clinical Diagnostics Holdings ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Ortho Clinical Diagnostics Holdings's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2022 was 5.64%.

As of today (2024-04-26), Ortho Clinical Diagnostics Holdings's WACC % is 6.34%. Ortho Clinical Diagnostics Holdings's ROIC % is -0.11% (calculated using TTM income statement data). Ortho Clinical Diagnostics Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Ortho Clinical Diagnostics Holdings ROIC % Historical Data

The historical data trend for Ortho Clinical Diagnostics Holdings's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortho Clinical Diagnostics Holdings ROIC % Chart

Ortho Clinical Diagnostics Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21
ROIC %
- 5.19 2.82 2.84 16.19

Ortho Clinical Diagnostics Holdings Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.45 17.70 5.49 18.54 5.64

Competitive Comparison of Ortho Clinical Diagnostics Holdings's ROIC %

For the Diagnostics & Research subindustry, Ortho Clinical Diagnostics Holdings's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortho Clinical Diagnostics Holdings's ROIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Ortho Clinical Diagnostics Holdings's ROIC % distribution charts can be found below:

* The bar in red indicates where Ortho Clinical Diagnostics Holdings's ROIC % falls into.



Ortho Clinical Diagnostics Holdings ROIC % Calculation

Ortho Clinical Diagnostics Holdings's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2021 is calculated as:

ROIC % (A: Dec. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2020 ) + Invested Capital (A: Dec. 2021 ))/ count )
=220.6 * ( 1 - -108.85% )/( (2973.7 + 2716.1)/ 2 )
=460.7231/2844.9
=16.19 %

where

Ortho Clinical Diagnostics Holdings's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2022 is calculated as:

ROIC % (Q: Mar. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2021 ) + Invested Capital (Q: Mar. 2022 ))/ count )
=189.2 * ( 1 - 19.13% )/( (2716.1 + 2710.4)/ 2 )
=153.00604/2713.25
=5.64 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2022) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortho Clinical Diagnostics Holdings  (NAS:OCDX) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Ortho Clinical Diagnostics Holdings's WACC % is 6.34%. Ortho Clinical Diagnostics Holdings's ROIC % is -0.11% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Ortho Clinical Diagnostics Holdings ROIC % Related Terms

Thank you for viewing the detailed overview of Ortho Clinical Diagnostics Holdings's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortho Clinical Diagnostics Holdings (Ortho Clinical Diagnostics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1001 Route 202, Raritan, NJ, USA, 08869
Ortho Clinical Diagnostics Holdings PLC offers in vitro diagnostics solutions and services. It provides diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. The company operates through three geographic segments such as Americas, EMEA, Greater China, and Other. Americas segment generates most of the revenue for the firm.
Executives
Robert Clifton Yates director C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Chockalingam Palaniappan officer: Chief Innovation Officer C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Christopher M Smith director, officer: Chairman and CEO 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Michael S. Iskra officer: Executive Vice President C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS, 1001 ROUTE 202, RARITAN NJ 08869
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015
Michael A. Schlesinger officer: EVP, GC and Secretary C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS 1001 ROUTE 202 RARITAN NJ 08869
Carlyle Partners Vi Cayman Holdings, L.p. 10 percent owner C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Tc Group Vi Cayman, L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Vi Cayman, L.p. 10 percent owner C/O WALKERS CORPORATE LIMITED, CAYMAN CORPORATE CENTRE, 27 HOSPITAL RD., GEORGE TOWN, GRAND CAYMAN E9 KY1-9008
Cg Subsidiary Holdings L.l.c. 10 percent owner C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings Sub L.p. 10 percent owner C/O WALKER CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001
Carlyle Holdings Ii L.l.c. 10 percent owner C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Holdings Ii Gp L.l.c. 10 percent owner C/O THE CARLYLE GROUP L.P., 1001 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20004-2505
Carlyle Group Inc. 10 percent owner C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tc Group Cayman Investment Holdings, L.p. 10 percent owner C/O WALKERS CORPORATE SERVICES LIMITED, 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN E9 KY1-9001